Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-10-08 Ownership | 2022-02-15 4:41 pm | N/A N/A | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 55,555 | $0.18 | 20,747,827 (Direct) | View |
2021-11-02 Ownership | 2022-02-15 4:41 pm | 2021-11-02 2023-10-31 | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 640,000 | $0.25 | 20,747,827 (Direct) | View |
2019-10-23 Ownership | 2022-02-15 4:41 pm | N/A N/A | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 500,000 | $0.1 | 20,747,827 (Direct) | View |
2021-09-02 Ownership | 2022-02-15 4:41 pm | 2021-09-02 2026-09-02 | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 2,000,000 | $0.13 | 20,747,827 (Direct) | View |
2021-06-08 Ownership | 2022-02-15 4:41 pm | N/A N/A | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 227,272 | $0.11 | 20,747,827 (Direct) | View |
2019-01-15 Ownership | 2022-02-15 4:41 pm | 2020-01-15 2024-01-15 | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 3,000,000 | $0.035 | 20,747,827 (Direct) | View |
2021-08-31 Ownership | 2022-02-15 4:41 pm | N/A N/A | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 750,000 | $0.13333 | 20,747,827 (Direct) | View |
2020-03-03 Ownership | 2022-02-15 4:41 pm | N/A N/A | AngioGenex Inc. | AGGX | ARONSTEIN MICHAEL CHAIRMAN 10% Owner | 75,000 | $0.2 | 20,747,827 (Direct) | View |